1. The neurological sequelae of pandemics and epidemics

   • Fernanda Valerio
   • Daniel P. Whitehouse
   • Virginia F. J. Newcombe

   Review Open access 26 October 2020 Pages: 2629 - 2655

   

2. Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature

   • Federico Cagnazzo
   • Caroline Arquizan
   • Vincent Costalat

   Review 30 October 2020 Pages: 2656 - 2665

   

3. COVID-19 in Parkinson’s disease: what holds the key?

   • R. Sainz-Amo
   • B. Baena-Álvarez
   • A. Alonso-Cánovas

   Original Communication 24 October 2020 Pages: 2666 - 2670

   

4. Intravenous immunoglobulin therapy in COVID-19-related encephalopathy

   • Lorenzo Muccioli
   • Umberto Pensato
   • Francesca Bisulli

   Original Communication Open access 08 October 2020 Pages: 2671 - 2675

   

5. Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses

   • François Lersy
   • Thibault Willaume
   • Stéphane Kremer

   Original Communication 21 November 2020 Pages: 2676 - 2684

   

6. Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19

   • Edward Needham
   • Virginia Newcombe
   • Stephen Sawcer

   Original Communication Open access 26 November 2020 Pages: 2685 - 2689

   

7. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review

   • Shitiz Sriwastava
   • Medha Tandon
   • Shumaila Sultan

   Short Commentary 12 October 2020 Pages: 2690 - 2696

   

8. COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience

   • Paolo Preziosa
   • Maria A. Rocca
   • Massimo Filippi

   Letter to the Editors 20 November 2020 Pages: 2697 - 2699

9. Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up

   • Julia V. Wanschitz
   • Manuela Kaml
   • Ronny Beer

   Letter to the Editors 20 November 2020 Pages: 2700 - 2702

   

10. Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis

    • Shengri Cong
    • Chunchen Xiang
    • Shuyan Cong

    Review 11 March 2020 Pages: 2703 - 2712

    

11. Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies

    • Yu Guo
    • Feng-Tao Liu
    • Jin-Tai Yu

    Review 12 March 2020 Pages: 2713 - 2722

    

12. Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: a systematic review of the literature

    • Angelos Sharobeam
    • Brett Jones
    • Christian J. Lueck

    Review 21 March 2020 Pages: 2723 - 2734

    

13. Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience—a European perspective

    • Manuel Toledo
    • Barbara Mostacci
    • Bettina Schmitz

    Review 01 April 2020 Pages: 2735 - 2748

    

14. Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis

    • Alhassane Diallo
    • Heike Jacobi
    • Thomas Klockgether

    Review 07 April 2020 Pages: 2749 - 2756

    

15. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features

    • Lisha Tang
    • Qianyi Huang
    • Xiangqi Tang

    Review 07 April 2020 Pages: 2757 - 2768

    

16. Neuronal surface autoantibodies in dementia: a systematic review and meta-analysis

    • Lucy L. Gibson
    • Anna McKeever
    • Thomas A. Pollak

    Review Open access 18 April 2020 Pages: 2769 - 2779

    

17. Heritable and non-heritable uncommon causes of stroke

    • A. Bersano
    • M. Kraemer
    • H. S. Markus

    Review 21 April 2020 Pages: 2780 - 2807

    

18. Correction to: Heritable and non-heritable uncommon causes of stroke

    • A. Bersano
    • M. Kraemer
    • H. S. Markus

    Correction 18 June 2020 Pages: 2808 - 2809

    

19. Early recurrent ischemic events after mechanical thrombectomy: effect of post-treatment intracranial hemorrhage

    • Junpei Koge
    • Kanta Tanaka
    • Kazunori Toyoda

    Original Communication 16 February 2021 Pages: 2810 - 2820

    

20. Long term follow-up in advanced Parkinson’s disease treated with DBS of the subthalamic nucleus

    • Maria Antonietta Volonté
    • Giacomo Clarizio
    • Massimo Filippi

    Original Communication 17 February 2021 Pages: 2821 - 2830

    

21. Effect of transcranial direct current stimulation on post-stroke fatigue

    • William De Doncker
    • Sasha Ondobaka
    • Annapoorna Kuppuswamy

    Original Communication Open access 17 February 2021 Pages: 2831 - 2842

    

22. Deficient visuomotor hand coordination in normal pressure hydrocephalus

    • Hannah Köster
    • Katharina Müller-Schmitz
    • Rüdiger J. Seitz

    Original Communication Open access 17 February 2021 Pages: 2843 - 2850

    

23. Central positional nystagmus in inferior cerebellar peduncle lesions: a case series

    • Sun-Uk Lee
    • Hyo-Jung Kim
    • Ji-Soo Kim

    Original Communication 18 February 2021 Pages: 2851 - 2857

    

24. First measured retinal nerve fiber layer thickness in RRMS can be used as a biomarker for the course of the disease: threshold value discussions

    • Vedat Cilingir
    • Muhammed Batur

    Original Communication 19 February 2021 Pages: 2858 - 2865

    

25. Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)

    • Veronica Villani
    • Elena Anghileri
    • Andrea Pace

    Original Communication 20 February 2021 Pages: 2866 - 2875

    

26. Heterogeneity of behavioural and language deficits in FTD–MND

    • Zhe Long
    • Muireann Irish
    • James R. Burrell

    Original Communication 20 February 2021 Pages: 2876 - 2889

    

27. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma

    • Aurelian Ungureanu
    • Magali Le Garff-Tavernier
    • Guido Ahle

    Original Communication 20 February 2021 Pages: 2890 - 2894

    

28. Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy

    • Rosa Cortese
    • Luca Prosperini
    • Carla Tortorella

    Original Communication 20 February 2021 Pages: 2895 - 2899

    

29. Event-related potentials using the auditory novel paradigm in patients with myotonic dystrophy

    • Shugo Suwazono
    • Hiroshi Arao
    • Shino Maedou

    Original Communication 20 February 2021 Pages: 2900 - 2907

    

30. CIDP associated with Sjögren’s syndrome

    • Tabea Seeliger
    • Stefan Gingele
    • Thomas Skripuletz

    Original Communication 21 February 2021 Pages: 2908 - 2912

31. Evolution of caloric responses during and between the attacks of Meniere’s disease

    • Sun-Uk Lee
    • Hyo-Jung Kim
    • Ji-Soo Kim

    Original Communication 21 February 2021 Pages: 2913 - 2921

    

32. Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study

    • Sebastiano Bucello
    • Pietro Annovazzi
    • Luca Prosperini

    Original Communication 22 February 2021 Pages: 2922 - 2932

    

33. Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in Japan

    • Rino Inada
    • Makito Hirano
    • Susumu Kusunoki

    Original Communication 24 February 2021 Pages: 2933 - 2942

    

34. The impact of interrupting enzyme replacement therapy in late-onset Pompe disease

    • Stephan Wenninger
    • Kristina Gutschmidt
    • Benedikt Schoser

    Original Communication Open access 24 February 2021 Pages: 2943 - 2950

    

35. Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study

    • Chung-Yao Chen
    • Chia-Ling Chen
    • Chung-Chieh Yu

    Original Communication 24 February 2021 Pages: 2951 - 2960

    

36. Contribution of neuropsychiatric symptoms in Parkinson’s disease to different domains of caregiver burden

    • L. M. Chahine
    • R. Feldman
    • C. Marras

    Original Communication Open access 25 February 2021 Pages: 2961 - 2972

    

37. Time-trend evolution and determinants of sex ratio in Amyotrophic Lateral Sclerosis: a dose–response meta-analysis

    • Andrea Fontana
    • Benoit Marin
    • Massimilano Copetti

    Original Communication 25 February 2021 Pages: 2973 - 2984

    

38. Quantitative analysis of dysautonomia in patients with autonomic dysreflexia

    • Nora Cívicos Sánchez
    • Marian Acera
    • Juan Carlos Gómez Esteban

    Original Communication 25 February 2021 Pages: 2985 - 2994

    

39. Multifocal neutrophilic meningoencephalitis: a novel disorder responsive to anakinra

    • Joseph R. Berger
    • Clyde Markowitz
    • Zissimos Mourelatos

    Original Communication 26 February 2021 Pages: 2995 - 2999

    

40. Recurrent seizures of autoimmune origin: emerging phenotypes

    • Mathilde Goudot
    • Solène Frismand
    • Louise Tyvaert

    Original Communication 27 February 2021 Pages: 3000 - 3010

    

41. Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up

    • Laura Fionda
    • Antonella Di Pasquale
    • Giovanni Antonini

    Original Communication 27 February 2021 Pages: 3011 - 3019

    

42. Predictors and outcomes of ischemic stroke in reversible cerebral vasoconstriction syndrome

    • Aayushi Garg
    • Matthew Starr
    • Santiago Ortega-Gutierrez

    Original Communication 01 March 2021 Pages: 3020 - 3025

43. An overview of viral infections of the nervous system in the immunosuppressed

    • Peter G. E. Kennedy

    Neurological Update Open access 13 October 2020 Pages: 3026 - 3030

44. DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder

    • Aiysha Chaudhry
    • Alkyoni Anthanasiou-Fragkouli
    • Henry Houlden

    Neurological Update Open access 26 October 2020 Pages: 3031 - 3041

    

45. Correction to: DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder

    • Aiysha Chaudhry
    • Alkyoni Athanasiou-Fragkouli
    • Henry Houlden

    Correction Open access 21 June 2021 Pages: 3042 - 3042

46. Contribution of multi-modal imaging to our understanding of dystonia pathogenesis

    • Claire MacIver
    • Kathryn Peall

    Journal Club Open access 14 July 2021 Pages: 3043 - 3045

47. Janina Hurynowicz (1894–1967)

    • Anita Magowska
    • Piotr Skalski

    Pioneers in Neurology Open access 14 October 2020 Pages: 3046 - 3048

    

48. Adolph Seeligmüller (1837–1912)

    • Carolin Arendt
    • Stephan Zierz

    Pioneers in Neurology Open access 21 October 2020 Pages: 3049 - 3051

    

49. Hans Joachim Scherer (1906–1945)

    • José Berciano

    Pioneers in Neurology 11 November 2020 Pages: 3052 - 3053

    

50. Ludwig Horn (1897–1935)

    • Lazaros C. Triarhou

    Pioneers in Neurology 13 November 2020 Pages: 3054 - 3055